SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 8.98% growth in the revenue at Rs. 5512.00 millions for the quarter ended June 2022 as compared to Rs. 5057.90 millions during the year-ago period.The Company to register a -42.14%  fall in the net profit for the quarter ended June 2022.The company reported a degrowth in operating Profit to 549.70 millions from 759.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 5512.00 5057.90 8.98 5512.00 5057.90 8.98 22511.70 19148.90 17.56
Other Income 2.40 16.40 -85.37 2.40 16.40 -85.37 47.80 64.20 -25.55
PBIDT 549.70 759.10 -27.59 549.70 759.10 -27.59 3229.50 4077.00 -20.79
Interest 67.90 41.10 65.21 67.90 41.10 65.21 200.60 226.10 -11.28
PBDT 481.80 718.00 -32.90 481.80 718.00 -32.90 3028.90 3853.10 -21.39
Depreciation 118.30 117.60 0.60 118.30 117.60 0.60 473.90 476.00 -0.44
PBT 363.50 600.40 -39.46 363.50 600.40 -39.46 2555.00 3377.10 -24.34
TAX 100.00 145.00 -31.03 100.00 145.00 -31.03 605.00 800.00 -24.38
Deferred Tax 10.00 -5.00 -300.00 10.00 -5.00 -300.00 -50.00 -45.00 11.11
PAT 263.50 455.40 -42.14 263.50 455.40 -42.14 1950.00 2577.10 -24.33
Equity 926.00 926.00 0.00 926.00 926.00 0.00 926.00 932.00 -0.64
PBIDTM(%) 9.97 15.01 -33.55 9.97 15.01 -33.55 14.35 21.29 -32.62

Aarti Drugs Share Price

370.75 0.50 (0.14%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: